First-line therapy for chronic graft-versus-host disease that includes low-dose methotrexate is associated with a high response rate.

First-line therapy for chronic graft-versus-host disease that includes low-dose methotrexate is associated with a high response rate.

Item
http://www.wikidata.org/entity/Q33383699
Graft-versus-host disease affecting oral cavity. A reviewSafety and efficacy of low-dose methotrexate for pediatric patients with steroid-refractory acute graft-versus-host disease after hematopoietic stem cell transplantation.Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go.Treatment and management of graft-versus-host disease: improving response and survival.State-of-the-art acute and chronic GVHD treatment.Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment.Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT.
P2860

First-line therapy for chronic graft-versus-host disease that includes low-dose methotrexate is associated with a high response rate.

Item
http://www.wikidata.org/entity/Q33383699
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
First-line therapy for chronic ...... ted with a high response rate.
@ast
First-line therapy for chronic ...... ted with a high response rate.
@en
type
label
First-line therapy for chronic ...... ted with a high response rate.
@ast
First-line therapy for chronic ...... ted with a high response rate.
@en
prefLabel
First-line therapy for chronic ...... ted with a high response rate.
@ast
First-line therapy for chronic ...... ted with a high response rate.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
First-line therapy for chronic ...... ted with a high response rate.
@en
P2093
P304
P31
P356
10.1016/J.BBMT.2008.12.493
P433
P478
P50
P577
P5875
P698